Caption Management’s Capricor Therapeutics CAPR Stock Holding History

Caption Management’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Buy	448,600 +226,800	+102%	+$6.88M	0.05%	379
2026 Q1	$6.74M	Sell	221,800 -401,200	-64%	-$10.7M	0.04%	440
2025 Q4	$18M	Buy	623,000 +164,400	+36%	+$2.15M	0.12%	197
2025 Q3	$3.31M	Sell	458,600 -438,900	-49%	-$3.23M	0.03%	637
2025 Q2	$8.91M	Buy	897,500 +797,500	+798%	+$8.42M	0.1%	236
2025 Q1	$949K	Sell	100,000 -278,000	-74%	-$3.86M	0.01%	939
2024 Q4	$5.22M	Sell	378,000 -434,900	-53%	-$7.62M	0.05%	354
2024 Q3	$12.4M	Buy	812,900 +682,400	+523%	+$3.38M	0.2%	123
2024 Q2	$622K	Buy	+130,500	New	+$728K	0.01%	770

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Caption Management's CAPR Position: Q2 2026 in Review

Caption Management opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 72,000 shares worth $1.73M. The stake represents 0.01% of the portfolio and ranks #949 among its holdings. This is a return to the name: Caption Management previously reported a position in CAPR as recently as Q1 2025.

Caption Management first reported a position in CAPR in Q1 2025 and has held it in 2 quarters since. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Caption Management held 72,000 shares of Capricor Therapeutics worth $1.73M as of Q2 2026.
Capricor Therapeutics was a new Caption Management position in Q2 2026.
Capricor Therapeutics made up 0.01% of Caption Management's portfolio in Q2 2026, its #949 holding.
Caption Management first reported a position in Capricor Therapeutics in Q1 2025 and has held it in 2 quarters since.
169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.